Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
about
Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
description
clinical trial
@en
klinisch onderzoek
@nl
name
Treatment Registry of Alectini ...... mall Cell Lung Cancer in Korea
@en
type
label
Treatment Registry of Alectini ...... mall Cell Lung Cancer in Korea
@en
prefLabel
Treatment Registry of Alectini ...... mall Cell Lung Cancer in Korea
@en
P6153
P1476
Treatment Registry of Alecensa ...... tic Non-Small Cell Lung Cancer
@en
P3098
NCT03271554
P580
2017-11-09T00:00:00Z
P582
2020-10-29T00:00:00Z